Grufity logoGrufity logo

Chemours Co Stock Research

CC

28.80USD+0.42(+1.48%)Delayed

Market Summary

USD28.80+0.42
Delayed
1.48%

CC Alerts

CC Stock Price

CC RSI Chart

CC Valuation

Market Cap

4.3B

Price/Earnings (Trailing)

7.4

Price/Sales (Trailing)

0.63

EV/EBITDA

5.59

Price/Free Cashflow

9.57

CC Price/Sales (Trailing)

CC Profitability

EBT Margin

10.91%

Return on Equity

52.21%

Return on Assets

7.57%

Free Cashflow Yield

10.45%

CC Fundamentals

CC Revenue

Revenue (TTM)

6.8B

Revenue Y/Y

-15.05%

Revenue Q/Q

-24.7%

CC Earnings

Earnings (TTM)

578.0M

Earnings Y/Y

-141.63%

Earnings Q/Q

-140.42%

Price Action

52 Week Range

23.4044.30
(Low)(High)

Last 7 days

-2.0%

Last 30 days

-14.1%

Last 90 days

-6.4%

Trailing 12 Months

-8.1%

CC Financial Health

Current Ratio

1.7

Debt/Equity

3.17

Debt/Cashflow

0.21

CC Investor Care

Dividend Yield

3.47%

Dividend/Share (TTM)

1

Buy Backs (1Y)

7.79%

Diluted EPS (TTM)

3.65

Peers (Alternatives to Chemours)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
34.3B
13.0B
-5.91% -9.14%
5.84
2.63
3.59% -9.26%
25.5B
7.3B
-11.63% 1.86%
9.49
3.49
119.96% 2074.96%
14.8B
5.8B
-8.58% -11.28%
20.13
2.56
15.01% -0.42%
11.0B
-
-11.07% -28.10%
5.82
1.15
22.25% 0.21%
MID-CAP
9.5B
10.6B
-4.57% -27.51%
12.04
0.9
0.99% -7.47%
6.9B
9.4B
-13.84% -1.19%
5.17
0.73
5.23% 2.33%
4.9B
8.0B
-7.01% -33.03%
10.74
0.62
4.60% -55.98%
4.3B
6.8B
-14.13% -8.14%
7.4
0.63
7.08% -4.93%
3.9B
942.4M
-8.55% -10.54%
37.42
4.18
17.94% 9.64%
3.7B
813.2M
-11.23% -19.45%
13.6
4.57
93.43% 45483.33%
2.4B
999.6M
1.27% 44.25%
215.39
2.37
3.34% -90.08%
SMALL-CAP
1.0B
1.9B
-21.72% -45.67%
9.68
0.52
-0.47% -7.44%
28.1M
68.4M
-18.79% -37.09%
2.41
0.41
48.74% 2401.42%

Financials for Chemours

Income Statement (Last 12 Months)
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Revenue-3.4%6,7947,0316,9346,6746,345
Gross Profit-10.6%1,6161,8081,8031,5701,381
Operating Expenses2.6%844823806730705
  S&GA Expenses2.3%710694678596592
  R&D Expenses1.7%118116111113107
EBITDA-23.9%1,1951,5701,5121,339-
EBITDA Margin-21.2%0.18*0.22*0.22*0.20*-
Earnings Before Taxes-33.4%7411,1121,044857676
EBT Margin-31.0%0.11*0.16*0.15*0.13*-
Interest Expenses-1.2%163165169176185
Net Income-36.3%578908882747608
Net Income Margin-34.1%0.09*0.13*0.13*0.11*-
Free Cahsflow-7.8%447485500460-
Balance Sheet
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Assets-1.4%7,6407,7457,7307,5247,550
  Current Assets-9.3%3,2143,5433,6063,3933,345
    Cash Equivalents-5.6%1,1021,1671,2481,1451,451
  Inventory6.3%1,4041,3211,2191,1661,099
  Net PPE3.3%3,1713,0713,1113,1313,154
  Goodwill0%102102102102102
Liabilities1.1%6,5336,4606,5156,3576,468
  Current Liabilities-3.1%1,8911,9511,8861,7751,858
  Long Term Debt-4.0%3,5103,6563,6923,724-
    LT Debt, Non Current2.3%3,5903,5103,6563,6923,724
Shareholder's Equity-13.8%1,1071,2841,2151,1671,081
  Retained Earnings-5.8%2,1702,3042,1021,9401,746
  Additional Paid-In Capital0.1%1,0161,0151,005956944
Accumulated Depreciation1.7%6,2166,1156,1536,1236,078
Shares Outstanding-3.0%149153156157161
Minority Interest0%1.001.001.001.00-
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Cashflow From Operations-6.7%754808818783820
  Share Based Compensation-20.6%27.0034.0031.0032.0034.00
Cashflow From Investing-239.9%-284203209187220
Cashflow From Financing1.6%-685-696-762-707-560
  Dividend Payments-2.5%154158160163164
  Buy Backs11.5%495444432317173

Risks for CC

What is the probability of a big loss on CC?

86.2%


Probability that Chemours stock will be more than 20% underwater in next one year

65.4%


Probability that Chemours stock will be more than 30% underwater in next one year.

57.3%


Probability that Chemours stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does CC drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Chemours was unfortunately bought at previous high price.

Drawdowns

Returns for CC

Cumulative Returns on CC

25.7%


7-Year Cumulative Returns

-5.8%


5-Year Cumulative Returns

49.7%


3-Year Cumulative Returns

What are the long-term rolling returns for CC?

FIve years rolling returns for Chemours.

Annualized Returns

Which funds bought or sold CC recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-03-15
B. Riley Wealth Advisors, Inc.
new
-
201,773
201,773
0.01%
2023-03-10
VICTORY CAPITAL MANAGEMENT INC
reduced
-0.02
205,471
1,052,470
-%
2023-03-08
SHEETS SMITH WEALTH MANAGEMENT
sold off
-100
-274,000
-
-%
2023-03-06
Rockefeller Capital Management L.P.
added
46.86
514,000
1,136,000
0.01%
2023-03-03
ROBOTTI ROBERT
reduced
-0.8
687,086
3,644,090
0.73%
2023-03-02
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA
new
-
377,239
377,239
-%
2023-02-28
Voya Investment Management LLC
reduced
-21.28
-31,707
1,398,290
-%
2023-02-24
NATIXIS
new
-
2,118,900
2,118,900
0.01%
2023-02-22
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
reduced
-6.04
110,000
763,000
0.01%
2023-02-22
CVA Family Office, LLC
reduced
-86.67
-7,469
1,531
-%

1–10 of 45

Latest Funds Activity

Are funds buying CC calls or puts?
Calls
Puts
Are funds bullish or bearish(Calls - Puts)?
Net Call Options
No. of funds that own CC
No. of Funds

Chemours News

MarketBeat

Assenagon Asset Management S.A. Invests $3.90 Million in The ....

MarketBeat,
6 hours ago

MarketBeat

Nasdaq

Chemours is Oversold.

Nasdaq,
11 days ago

Yahoo Finance

Schedule 13G FIlings of Chemours

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2023
sessa capital (master), l.p.
0.36%
547,057
SC 13G/A
Feb 09, 2023
fmr llc
-
0
SC 13G/A
Feb 09, 2023
vanguard group inc
12.20%
18,416,153
SC 13G/A
Jan 26, 2023
blackrock inc.
12.3%
18,516,903
SC 13G/A
Jan 20, 2023
blackrock inc.
12.3%
18,516,903
SC 13G/A
Apr 08, 2022
blackrock inc.
11.3%
18,075,740
SC 13G/A
Feb 14, 2022
sessa capital (master), l.p.
3.6%
5,748,120
SC 13G/A
Feb 09, 2022
vanguard group inc
9.98%
16,258,762
SC 13G/A
Feb 09, 2022
fmr llc
-
0
SC 13G/A
Feb 03, 2022
blackrock inc.
8.6%
14,015,490
SC 13G/A

CC Fair Value

Chemours fair value in different scenarios

The table shows the Fair Value estimates for Chemours for various scenarios. Disclaimer: These are just estimations from a model. None of the models are good at predicting the future. Please dont buy or sell stocks based on these outputs.
Fair ValueVery PessimisticPessimisticBase CaseOptimisticVery Optimistic
Very Low Inflation

21.94

-23.82%

31.44

9.17%

52.76

83.19%

71.62

148.68%

84.17

192.26%
Current Inflation

20.93

-27.33%

29.71

3.16%

47.69

65.59%

63.85

121.70%

74.51

158.72%
Very High Inflation

19.61

-31.91%

27.48

-4.58%

41.56

44.31%

54.63

89.69%

63.14

119.24%

Historical Chemours Fair Value Estimates


Very Pessimistic Case
Pessimistic Case
Fair Value
Optimistic Case
Very Optimistic Case
Closing Stock Price

Recent SEC filings of Chemours

View All Filings
Date Filed Form Type Document
Mar 23, 2023
8-K
Current Report
Mar 16, 2023
8-K
Current Report
Mar 15, 2023
8-K
Current Report
Mar 10, 2023
4/A
Insider Trading
Mar 10, 2023
DEFA14A
DEFA14A
Mar 10, 2023
DEF 14A
DEF 14A
Mar 10, 2023
ARS
ARS
Mar 10, 2023
4/A
Insider Trading
Mar 10, 2023
4/A
Insider Trading
Mar 10, 2023
4/A
Insider Trading

Latest Insider Trading transactions for CC

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-03-06
Bellezza Alisha
acquired
658,266
23.7504
27,716
president, thermal spec solns
2023-03-06
Bellezza Alisha
sold
-983,086
35.47
-27,716
president, thermal spec solns
2023-03-02
Dignam Denise
sold (taxes)
-20,552
36.12
-569
president, adv perf materials
2023-03-02
Sparks Edwin C
sold (taxes)
-653,014
36.12
-18,079
president, titan tech chem sol
2023-03-02
Scarborough Alvenia
sold (taxes)
-20,227
36.12
-560
svp corp communications & cbo
2023-03-02
Wellman Kristine M
sold (taxes)
-18,674
36.12
-517
svp, gc & corp. secretary
2023-03-02
Wisel Camela
sold (taxes)
-17,590
36.12
-487
vp, cao & controller
2023-03-02
Bellezza Alisha
sold (taxes)
-34,061
36.12
-943
president, thermal spec solns
2023-03-01
Newman Mark
sold (taxes)
-182,840
34.84
-5,248
president and ceo
2023-03-01
Scarborough Alvenia
acquired
-
-
2,332
svp corp communications & cbo

1–10 of 50

Mark E. Newman
6400
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through four segments: Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure and BaiMax brands for delivering whiteness, brightness, opacity, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging. The Thermal & Specialized Solutions segment offers of refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents. The Advanced Performance Materials segment products portfolio includes various industrial resins, specialty products, membranes, and coatings for consumer electronics, semiconductors, digital communications, transportation, energy, oil and gas, and medical, and others applications. The Chemical Solutions segment comprises a portfolio of industrial chemicals used as raw materials and catalysts for gold production, clean and disinfect, oil and gas, water treatment, electronics, and automotive applications. The company sells its products through direct and indirect channels, as well as through a network of resellers and distributors. The Chemours Company was founded in 2014 and is headquartered in Wilmington, Delaware.

CC Income Statement

2022-09-30
Interim Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Millions
3 Months Ended9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]    
Net sales$ 1,777$ 1,680$ 5,456$ 4,770
Cost of goods sold1,3451,2534,0423,782
Gross profit4324271,414988
Selling, general, and administrative expense140124535433
Research and development expense32278878
Restructuring, asset-related, and other charges(1)3104
Total other operating expenses171154633515
Equity in earnings of affiliates16124432
Interest expense, net(41)(45)(123)(142)
Gain (loss) on extinguishment of debt7(20)7(20)
Other income, net561110131
Income before income taxes299231810374
Provision for (benefit from) income taxes5917135(1)
Net income240214675375
Net income attributable to Chemours$ 240$ 214$ 675$ 375
Per share data    
Basic earnings per share of common stock$ 1.54$ 1.30$ 4.30$ 2.26
Diluted earnings per share of common stock$ 1.52$ 1.27$ 4.21$ 2.21

CC Balance Sheet

2022-09-30
Interim Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Millions
Sep. 30, 2022
Dec. 31, 2021
Current assets:  
Cash and cash equivalents$ 1,167$ 1,451
Accounts and notes receivable, net980720
Inventories1,3211,099
Prepaid expenses and other7575
Total current assets3,5433,345
Property, plant, and equipment9,1869,232
Less: Accumulated depreciation(6,115)(6,078)
Property, plant, and equipment, net3,0713,154
Operating lease right-of-use assets232227
Goodwill102102
Other intangible assets, net156
Investments in affiliates186169
Restricted cash and restricted cash equivalents201100
Other assets395447
Total assets7,7457,550
Current liabilities:  
Accounts payable1,2701,162
Compensation and other employee-related cost130173
Short-term and current maturities of long-term debt2425
Current environmental remediation210173
Other accrued liabilities317325
Total current liabilities1,9511,858
Long-term debt, net3,5103,724
Operating lease liabilities192179
Long-term environmental remediation482389
Deferred income taxes5349
Other liabilities272269
Total liabilities6,4606,468
Commitments and contingent liabilities (Note 16)
Equity  
Common stock (par value $0.01 per share; 810,000,000 shares authorized; 195,178,578 shares issued and 153,078,931 shares outstanding at September 30, 2022; 191,860,159 shares issued and 161,046,732 shares outstanding at December 31, 2021)22
Treasury stock, at cost (42,099,647 shares at September 30, 2022; 30,813,427 shares at December 31, 2021)(1,604)(1,247)
Additional paid-in capital1,015944
Retained earnings2,3041,746
Accumulated other comprehensive loss(433)(364)
Total Chemours stockholders’ equity1,2841,081
Non-controlling interests11
Total equity1,2851,082
Total liabilities and equity$ 7,745$ 7,550